AstraZeneca UK Limited (manufacturer, responsible for packaging and batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as for the prevention of their recurrence), and as adjunctive therapy for severe depressive episodes in patients with major depressive disorder.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 50 mg ATC: N05AH04
-
The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as the prevention of their recurrence), and as adjunctive therapy for severe depressive episodes in patients with major depressive disorder.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 200 mg ATC: N05AH04
-
The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as the prevention of their recurrence), and as adjunctive therapy for severe depressive episodes in patients with major depressive disorder.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 300 mg ATC: N05AH04
-
The drug is used for the treatment of schizophrenia, bipolar disorder (manic and depressive episodes, as well as for the prevention of their recurrence), and as adjunctive therapy for severe depressive episodes in patients with major depressive disorder.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 400 mg ATC: N05AH04